Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D135775-1mg | 1mg | In stock | $19.90 | |
D135775-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $82.90 | |
D135775-25mg | 25mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $260.90 |
Potent, selective and dual site Src tyrosine kinase family inhibitor
Synonyms | 179248-59-0|Src Kinase Inhibitor I|Src Inhibitor 1|Src I1|6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine|Src Inhibitor-1|4-Quinazolinamine, 6,7-dimethoxy-N-(4-phenoxyphenyl)-|Src-l1|6,7-dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine|Src I 1|CHEMBL97 |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of receptor interacting serine/threonine kinase 2 |
Product Description | Src kinase inhibitor I is a 4-anilinoquinazole competitive inhibitor of Src family tryosine kinases. Src kinase inhibitor I is a dual site inhibitor, described to compete at both the ATP and peptide binding sites of the kinase. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine |
---|---|
INCHI | InChI=1S/C22H19N3O3/c1-26-20-12-18-19(13-21(20)27-2)23-14-24-22(18)25-15-8-10-17(11-9-15)28-16-6-4-3-5-7-16/h3-14H,1-2H3,(H,23,24,25) |
InChi Key | DMWVGXGXHPOEPT-UHFFFAOYSA-N |
Canonical SMILES | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OC4=CC=CC=C4)OC |
Isomeric SMILES | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OC4=CC=CC=C4)OC |
WGK Germany | 3 |
PubChem CID | 1474853 |
Molecular Weight | 373.4 |
PubChem CID | 1474853 |
---|---|
ChEMBL Ligand | CHEMBL97771 |
CAS Registry No. | 179248-59-0 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H1810208 | Certificate of Analysis | Feb 20, 2024 | D135775 |
H1810209 | Certificate of Analysis | May 09, 2022 | D135775 |
E1620084 | Certificate of Analysis | Jan 25, 2022 | D135775 |
Solubility | Soluble in DMSO (>10 mg/ml). |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H413:May cause long lasting harmful effects to aquatic life H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
1. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P. (2007) The selectivity of protein kinase inhibitors: a further update.. Biochem J, 408 (3): (297-315). [PMID:17850214] |
2. Röselová P et al.. (2018) Adhesion structures in leukemia cells and their regulation by Src family kinases.. Cell Adh Migr, 12 (3): (286-298). [PMID:28678601] |
3. McGee D et al.. (2017) Cervical HSV-2 infection causes cervical remodeling and increases risk for ascending infection and preterm birth.. PLoS One, 12 (11): (e0188645). [PMID:29190738] |
4. Kumazoe M et al.. (2017) Green Tea Polyphenol EGCG Upregulates Tollip Expression by Suppressing Elf-1 Expression.. J Immunol, 199 (9): (3261-3269). [PMID:28954885] |
5. Wang X et al.. (2017) Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway.. J Med Virol, [PMID:28480962] |
6. Hock EM et al.. (2018) Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, but Not Astrocytic, FUS due to Impaired Transportin Function.. Cell Rep, 24 (4): (987-1000.e7). [PMID:30044993] |
7. Gomes JR et al.. (2016) Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia.. Cell Death Differ, 23 (11): (1749-1764). [PMID:27518433] |